Drugs / Xenetix
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01639703 | Apr 2012 → Oct 2014 | hepatocellular carcinoma | Guerbet | Completed | No outcome recorded |
| Phase 4 | NCT00347022 | May 2006 → Apr 2009 | — | Guerbet | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xenetix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00347022 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic Contribution of XENETIX® CT PERFUSION” NCT01639703 ↗ |